Form 8-K - Current report:
SEC Accession No. 0000950103-25-004416
Filing Date
2025-04-04
Accepted
2025-04-04 16:18:36
Documents
15
Period of Report
2025-04-01
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K dp227252_8k.htm   iXBRL 8-K 24778
5 EXHIBIT 10.1 dp227252_ex1001.htm EX-10.1 35013
6 GRAPHIC image_001.jpg GRAPHIC 1867
  Complete submission text file 0000950103-25-004416.txt   239217

Data Files

Seq Description Document Type Size
2 XBRL SCHEMA FILE endo-20250401.xsd EX-101.SCH 3002
3 XBRL LABEL FILE endo-20250401_lab.xml EX-101.LAB 34239
4 XBRL PRESENTATION FILE endo-20250401_pre.xml EX-101.PRE 22350
17 EXTRACTED XBRL INSTANCE DOCUMENT dp227252_8k_htm.xml XML 3219
Mailing Address 9 GREAT VALLEY PARKWAY MALVERN PA 19355
Business Address 9 GREAT VALLEY PARKWAY MALVERN PA 19355 (484) 216-0000
Endo, Inc. (Filer) CIK: 0002008861 (see all company filings)

EIN.: 301390281 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 333-280767 | Film No.: 25815015
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)